We previously showed in models of MYC amplification representing liver cancer (tumors and cell lines) and Burkitt’s Lymphoma that suppressing amplified MYC leads to changes in clock gene expression, including increasing BMAL1 (which suggested that MYC suppressed BMAL1 in these settings) [31,32]. The gene discussed is BMAL1; the disease is liver cancer.